Back to Search
MAYURI RAVI, D.O
D.O
Internal Medicine Physician
NPI: 1871024190IndividualAccepts Medicare
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
304549(NY)
Education
OTHER
Class of 2017
Research & Publications (20)
Discovery of 4-(benzylaminomethylene)isoquinoline-1,3-(2H,4H)-diones and 4-[(pyridylmethyl)aminomethylene]isoquinoline-1,3-(2H,4H)-diones as potent and selective inhibitors of the cyclin-dependent kinase 4.
PMID 19317452·J Med Chem·2009
7-preclinical
Postauricular skin as an alternative to oral mucosa for anterior onlay graft urethroplasty: a preliminary experience in patients with oral mucosa changes.
PMID 19428075·Urology·2009
8-other
The plant adherin AtSCC2 is required for embryogenesis and sister-chromatid cohesion during meiosis in Arabidopsis.
PMID 19228337·Plant J·2009
8-other
Clearance of white spot syndrome virus (WSSV) and immunological changes in experimentally WSSV-injected Macrobrachium rosenbergii.
PMID 18603447·Fish Shellfish Immunol·2008
7-preclinical
Lead identification to generate isoquinolinedione inhibitors of insulin-like growth factor receptor (IGF-1R) for potential use in cancer treatment.
PMID 18501599·Bioorg Med Chem Lett·2008
8-other
4-(Phenylaminomethylene)isoquinoline-1,3(2H,4H)-diones as potent and selective inhibitors of the cyclin-dependent kinase 4 (CDK4).
PMID 18494457·J Med Chem·2008
8-other
Hybridoma generation by in vitro immunization of murine splenocytes with cytosolic proteins of Chinese hamster ovary (CHO) mitotic cells.
PMID 17979547·Hybridoma (Larchmt)·2007
7-preclinical
Contribution of AIDA-I to the pathogenicity of a porcine diarrheagenic Escherichia coli and to intestinal colonization through biofilm formation in pigs.
PMID 17140750·Vet Microbiol·2007
4-observational
Dual irreversible kinase inhibitors: quinazoline-based inhibitors incorporating two independent reactive centers with each targeting different cysteine residues in the kinase domains of EGFR and VEGFR-2.
PMID 17416531·Bioorg Med Chem·2007
8-other
Free-energy force-field three-dimensional quantitative structure-activity relationship analysis of a set of p38-mitogen activated protein kinase inhibitors.
PMID 16541250·J Mol Model·2006
8-other
3D-QSAR studies on antitubercular thymidine monophosphate kinase inhibitors based on different alignment methods.
PMID 16290929·Bioorg Med Chem Lett·2006
8-other
AtMND1 is required for homologous pairing during meiosis in Arabidopsis.
PMID 16872528·BMC Mol Biol·2006
8-other
Construction of 4D-QSAR models for use in the design of novel p38-MAPK inhibitors.
PMID 16231199·J Comput Aided Mol Des·2005
4-observational
Structure-based identification of the binding site for the hemiasterlin analogue HTI-286 on tubulin.
PMID 16313189·Biochemistry·2005
8-other
2-(Quinazolin-4-ylamino)-[1,4]benzoquinones as covalent-binding, irreversible inhibitors of the kinase domain of vascular endothelial growth factor receptor-2.
PMID 16302797·J Med Chem·2005
7-preclinical
4-Anilino-7,8-dialkoxybenzo[g]quinoline-3-carbonitriles as potent Src kinase inhibitors.
PMID 16161995·J Med Chem·2005
7-preclinical
Takayasu's arteritis with bilateral anterior ischaemic optic atrophy.
PMID 15909864·J Assoc Physicians India·2004
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 300 COMMUNITY DR
MANHASSET, NY 11030 - Phone
- (516) 562-2945
Quick Facts
- NPI
- 1871024190
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 9
- Publications
- 20
Are you this provider?
Claim Your Profile